Cite
Attitudes, perceptions and barriers in implementing therapeutic drug monitoring for anti-TNFs in inflammatory bowel disease: a survey from the Middle East.
MLA
Nigam, Gaurav B., et al. “Attitudes, Perceptions and Barriers in Implementing Therapeutic Drug Monitoring for Anti-TNFs in Inflammatory Bowel Disease: A Survey from the Middle East.” Therapeutic Advances in Gastroenterology, vol. 17, Feb. 2024, p. 17562848241230902. EBSCOhost, https://doi.org/10.1177/17562848241230902.
APA
Nigam, G. B., Chatten, K., Sharara, A., Al-Taweel, T., Alharbi, O., Elamin, H., Al Awadhi, S., Annese, V., & Limdi, J. K. (2024). Attitudes, perceptions and barriers in implementing therapeutic drug monitoring for anti-TNFs in inflammatory bowel disease: a survey from the Middle East. Therapeutic Advances in Gastroenterology, 17, 17562848241230902. https://doi.org/10.1177/17562848241230902
Chicago
Nigam, Gaurav B, Kelly Chatten, Ala Sharara, Talal Al-Taweel, Othman Alharbi, Hussein Elamin, Sameer Al Awadhi, Vito Annese, and Jimmy K Limdi. 2024. “Attitudes, Perceptions and Barriers in Implementing Therapeutic Drug Monitoring for Anti-TNFs in Inflammatory Bowel Disease: A Survey from the Middle East.” Therapeutic Advances in Gastroenterology 17 (February): 17562848241230902. doi:10.1177/17562848241230902.